Payments for colon cancer treatments vary extensively, researchers concluded after conducting a study involving >18,000 individuals. Patients underwent a colectomy for colon cancer between 2010 and 2014. Investigators calculated and compared risk-adjusted payments. Among the results:
- The median risk-adjusted payment for surgery was ~$26,400.
- Payments ranged between ~ $19,800 among patients in the lowest quartile of payments to ~$33,800 for patients in the highest quartile.
- The median risk-adjusted payment for chemotherapy was ~$70,100.
- Chemotherapy payments were 40% higher in patients in the highest vs lowest quartile.
- Patients in the highest two quartiles comprised 59% of all payments.
- Patients who were younger, had increasing comorbidities, or underwent an open operation tended to have higher overall payments.
Gani F, Cerullo M, Canner J, et al. Defining payments associated with the treatment of colorectal cancer. J Surg Res. 2017;220:284-292. doi:10.1016/j.jss.2017.07.021.